Kenneth Offit, MD
PHILADELPHIA – The Basser Center for BRCA at the Abramson Cancer Center of the University of Pennsylvania, the world’s first comprehensive center aimed at advancing research, treatment, and prevention of BRCA-related cancers, has announced Kenneth Offit, MD, MPH, Memorial Sloan Kettering Cancer Center (MSK) as the recipient of the 2023 Basser Global Prize.
Each year, the Basser Global Prize recognizes a leading scientist who has advanced BRCA1 and BRCA2-related research. Individuals with mutations in the BRCA1 and BRCA2 genes are at an increased risk of breast, ovarian, pancreatic, and prostate cancers.
Offit’s work identified the most common mutation associated with an increased risk of breast, ovarian, and prostate cancer among individuals of Ashkenazi Jewish ancestry. He also published the first prospective series describing the outcome of preventive ovarian surgery and screening in women at hereditary risk for breast and ovarian cancer.
“We are pleased to honor Dr. Offit for his seminal work in clinical cancer genetics and for translating his research into preventive oncology practice to help educate clinicians and BRCA gene mutation carriers about cancer predisposition,” said Susan M. Domchek, MD, executive director of the Basser Center for BRCA. “His work aligns closely with the Basser Center’s mission to use cutting edge research in basic and clinical sciences to advance the care of individuals living with BRCA1 and BRCA2 mutations.”
Offit, who received his MD and MPH from Harvard University, is the Robert and Kate Niehaus Chair in Inherited Cancer Genomics and serves as chief of the Clinical Genetics Service at MSK. He founded one of the first clinical cancer genetics services in 1992 and led the first American Society of Clinical Oncology policy statement after the identification of BRCA1 and BRCA2. His ongoing research includes leading an implementation study, funded by the National Institutes of Health, to pilot digital health dissemination of genomic information.
“It is an honor to be recognized with this award from the Basser Center, which is making a difference for patients with inherited BRCA1 and BRCA2 mutations across the world,” Offit said.
Offit will give the keynote address at the 12th annual Basser Center Scientific Symposium, taking place May 13-14, 2024.
The Basser Global Prize provides $100,000 in unrestricted support of the winner's BRCA1 and BRCA2-related research efforts, a Basser sculpture, and a $10,000 personal prize, which will be awarded at the symposium.
The Basser Center was established in 2012 by University of Pennsylvania alumni Mindy and Jon Gray in memory of Mindy Gray’s sister Faith Basser, who died of ovarian cancer at age 44. Mindy’s sister Shari and her husband, Len Potter, established and endowed the Basser Global Prize.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.